Maitland, Florida
CNS medication trials in Maitland, FL
26 CNS medication studies are recruiting participants at sites in Maitland as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Maitland at a glance
- 26 studies are recruiting at a site in Maitland.
- By phase: Phase 1 (1), Phase 2 (5), Phase 2/3 (1), Phase 3 (18), Phase 4 (1).
- By sponsor: industry (26).
- By research area: Depression (8), Multiple Sclerosis (5), ADHD (4), Schizophrenia (4), Parkinson's Disease (3), Bipolar Disorder (1), Epilepsy (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Maitland
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Study site
- Accel Research Sites - Maitland
- Registry record
- NCT06793397 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Study site
- K2 Medical Research (Maitland)
- Registry record
- NCT07592689 · updated
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- K2 Medical Research - Maitland
- Registry record
- NCT07412756 · updated
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- K2 Medical Research
- Registry record
- NCT07573176 · updated
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06966401 · updated
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Registry record
- NCT07621237 · updated
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06963021 · updated
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06786624 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Maitland, FL on ClinicalTrials.gov.
Schizophrenia studies recruiting in Maitland
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- K2 Medical Research
- Registry record
- NCT06540833 · updated
A Study of Brenipatide in Adult Participants With Schizophrenia
- Phase 2
- Ages 18 to 55
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Accel Research Sites - Maitland Clinical Research Unit
- Registry record
- NCT07410507 · updated
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07114874 · updated
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07227818 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Maitland, FL on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Maitland
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study sites
- Accel Research Sites - Maitland Clinical Research Unit · K2 Medical Research - Maitland
- Registry record
- NCT07286175 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Maitland, FL on ClinicalTrials.gov.
ADHD studies recruiting in Maitland
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Study site
- Accel Research Sites-Maitland
- Registry record
- NCT07759154 · updated
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Alkermes, Inc.
- Study sites
- Alkermes Investigational Site · Alkermes Investigator Site
- Registry record
- NCT07755410 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Maitland, FL on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Maitland
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Phase 1
- Ages 40 to 80
- All sexes
- Sponsor
- Serina Therapeutics
- Study site
- K2 Medical Research LLC
- Registry record
- NCT07422675 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- K2 Medical Research-Maitland
- Registry record
- NCT07174310 · updated
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Maitland, FL on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Maitland
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Study site
- Neurology Associates
- Registry record
- NCT07299019 · updated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Study site
- Neurology Associates, PA
- Registry record
- NCT07067463 · updated
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Phase 4
- Ages 18 to 65
- All sexes
- Sponsor
- Genentech, Inc.
- Study site
- Neurology Associates, PA
- Registry record
- NCT07609719 · updated
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Phase 3
- Ages 40 to 70
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Neurology Associates PA
- Registry record
- NCT06846281 · updated
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Neurology Associates PA
- Registry record
- NCT07225504 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Maitland, FL on ClinicalTrials.gov.
Epilepsy studies recruiting in Maitland
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Registry record
- NCT07594119 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Maitland, FL on ClinicalTrials.gov.
Ask about studies near Maitland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
142 studies recruiting across 67 cities.
Miami
55 studies recruiting.
Tampa
54 studies recruiting.
Orlando
48 studies recruiting.
Hollywood
31 studies recruiting.
Jacksonville
30 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections